What a Blood Smear Will Tell You in This Context
In a patient with elevated serum vitamin B12 and mild cytopenias, the peripheral blood smear is mandatory and will reveal critical morphologic features that help distinguish between myelodysplastic syndrome (MDS), masked B12 deficiency due to assay interference, and other hematologic disorders. 1
Key Morphologic Features to Identify
For MDS Evaluation
The blood smear serves as a mandatory diagnostic tool for evaluating dysplasia in one or more cell lines and enumerating blasts 1. Specifically look for:
Erythroid dysplasia:
- Anisocytosis (variation in red cell size)
- Poikilocytosis (variation in red cell shape)
- Basophilic stippling 1
Myeloid dysplasia:
- Granulocyte nuclear hypolobation (pseudo Pelger-Huet anomaly)
- Granulocyte cytoplasmic hypogranulation or degranulation
- Presence of blasts 1
Megakaryocytic dysplasia:
- Platelet anisocytosis
- Giant platelets 1
For Paradoxical B12 Deficiency
Despite the elevated serum B12, the smear may paradoxically show megaloblastic features that suggest true B12 deficiency:
- Macrocytosis with oval macrocytes - the hallmark finding 2
- Anisopoikilocytosis (marked variation in red cell size and shape) 3, 2
- Hypersegmented neutrophils - a critical diagnostic clue 2
- Absence of schistocytes (rules out microangiopathic hemolysis) 3
Critical Diagnostic Pitfall
The elevated B12 level may be falsely elevated due to anti-intrinsic factor antibody interference with the assay 4. This creates a dangerous diagnostic trap where:
- The smear shows megaloblastic changes consistent with B12 deficiency
- But the lab reports high B12 levels (sometimes >2000 pmol/L)
- This occurs in pernicious anemia when anti-intrinsic factor antibodies interfere with immunoassays 4
Algorithmic Approach to Interpretation
If the smear shows:
Dysplastic features (>10% of cells in affected lineage) + blasts → Pursue MDS workup with bone marrow biopsy and cytogenetics (mandatory) 1
Megaloblastic changes (macrocytosis, hypersegmented neutrophils) despite elevated B12 → Check anti-intrinsic factor antibodies immediately, as this suggests masked B12 deficiency requiring empirical B12 replacement 4
Hemolytic features (anisopoikilocytosis) + macrocytosis + inappropriately low reticulocytes → Consider intramedullary hemolysis from severe B12 deficiency, even with elevated serum B12 3, 2
Mild dysplasia without robust markers (no ring sideroblasts, no excess blasts, normal cytogenetics) → Observe for 6 months with repeat bone marrow before diagnosing MDS, as rapid progression is unlikely 1
Additional Smear Findings That Guide Management
The reticulocyte count relative to anemia severity provides crucial context:
- Inappropriately low reticulocytes for the degree of anemia suggest ineffective erythropoiesis, seen in both MDS and B12 deficiency 2
- Negative Coombs test + mild reticulocytosis + macrocytosis points toward B12 deficiency mimicking hemolytic anemia rather than true autoimmune hemolysis 3
Why This Matters for Outcomes
Missing masked B12 deficiency leads to irreversible neurologic damage if untreated, while misdiagnosing it as MDS subjects patients to unnecessary bone marrow biopsies and inappropriate chemotherapy 4. Conversely, attributing true MDS to B12 deficiency delays potentially life-saving treatment for a malignant condition.
The blood smear must be examined by counting at least 200 cells to accurately assess dysplasia 1. The presence of hypersegmented neutrophils with macrocytosis should trigger anti-intrinsic factor antibody testing regardless of the B12 level, as assay interference can completely mask true deficiency 4.